IMMUNOCELLULAR THERAPEUTICS, LTD. AND , AS WARRANT AGENT PREFERRED STOCK WARRANT AGREEMENT DATED AS OFPreferred Stock Warrant Agreement • September 21st, 2012 • ImmunoCellular Therapeutics, Ltd. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 21st, 2012 Company Industry JurisdictionTHIS PREFERRED STOCK WARRANT AGREEMENT (this “Agreement”), dated as of [•], between IMMUNOCELLULAR THERAPEUTICS, LTD., a Delaware corporation (the “Company”) and [•], a [corporation] [national banking association] organized and existing under the laws of [•] and having a corporate trust office in [•], as warrant agent (the “Warrant Agent”).
IMMUNOCELLULAR THERAPEUTICS, LTD. AND , AS WARRANT AGENT DEBT SECURITIES WARRANT AGREEMENT DATED AS OFWarrant Agreement • September 21st, 2012 • ImmunoCellular Therapeutics, Ltd. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 21st, 2012 Company Industry JurisdictionTHIS DEBT SECURITIES WARRANT AGREEMENT (this “Agreement”), dated as of [•], between IMMUNOCELLULAR THERAPEUTICS, LTD., a Delaware corporation (the “Company”) and [•], a [corporation] [national banking association] organized and existing under the laws of [•] and having a corporate trust office in [•], as warrant agent (the “Warrant Agent”).
IMMUNOCELLULAR THERAPEUTICS, LTD. AND , AS WARRANT AGENT Common Stock Warrant Agreement DATED AS OFWarrant Agreement • September 21st, 2012 • ImmunoCellular Therapeutics, Ltd. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 21st, 2012 Company Industry JurisdictionTHIS COMMON STOCK WARRANT AGREEMENT (this “Agreement”), dated as of [•], between IMMUNOCELLULAR THERAPEUTICS, LTD., a Delaware corporation (the “Company”) and [•], a [corporation] [national banking association] organized and existing under the laws of [•] and having a corporate trust office in [•], as warrant agent (the “Warrant Agent”).